A four-site research consortium is launching studies of how mutations in the LRKK2 and Parkin genes may cause immune dysfunction that leads to Parkinson disease.
A $3.8M NIH grant will help a Cleveland Clinic researcher create a predictive mathematical model for dementia development based on imaging and non-imaging measures.
New funding will expand the LARGE-PD cohort study of Parkinson disease in Latinos to include a genome-wide association study and develop a Latino-specific polygenic risk score for PD.
Our Neurological Institute is introducing a smartphone app that augments virtual visits by replicating portions of the physical exam by allowing patients to self-administer neuroperformance tests at home.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Only about 10% of candidates for surgical intervention for movement disorders end up undergoing surgery. Our latest podcast discusses new approaches that may increase that percentage.
With scarce data on how these conditions affect each other, nimbleness may be the best tool neurologists can deploy when managing movement disorders in this time of pandemic.
We’ve been collecting objective, quantitative outcomes at scale among populations with multiple sclerosis and Parkinson disease to unleash the potential of data-guided care. Here are some promising status reports.
Subject matter expert James Leverenz, MD, explains how he distinguishes between the two main forms of this poorly understood group of dementias and where diagnosis and treatment appear to be headed.
A new episode of our “Neuro Pathways” podcast explores how key insights into this condition have shifted in recent years and why the changes raise hope for long-elusive treatment progress.
As demand swells for movement disorder expertise, a special journal issue from the World Congress on Parkinson’s Disease and Related Disorders delivers an essential update for neurologists worldwide.